Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1371878 | Bioorganic & Medicinal Chemistry Letters | 2009 | 5 Pages |
Abstract
Utilizing structure-based drug design, a 4-aminoimidazole heterocyclic core was synthesized as a replacement for a 2-aminothiazole due to potential metabolically mediated toxicity. The synthetic route utilized allowed for ready synthesis of 1-substituted-4-aminoimidazoles. SAR exploration resulted in the identification of a novel cis-substituted cyclobutyl group that gave improved enzyme and cellular potency against cdk5/p25 with up to 30-fold selectivity over cdk2/cyclin E.
Graphical abstractUsing structure-based drug design, 4-aminoimidazoles were prepared with potent inhibition of cdk5/p25 in enzyme and whole cell assays and selectivity over cdk2.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Christopher J. Helal, Zhijun Kang, John C. Lucas, Thomas Gant, Michael K. Ahlijanian, Joel B. Schachter, Karl E.G. Richter, James M. Cook, Frank S. Menniti, Kristin Kelly, Scot Mente, Jay Pandit, Natalie Hosea,